Is a complete AEON research report available?

No complete published report is available for AEON Biopharma, Inc. (AEON) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

AEON Biopharma, Inc. (AEON)

NYSEAMERICAN: AEON · USD

$0.27

+0.02 (+8.3%)· Recorded snapshot

Market cap	13.4M
Net income (ttm)	-54.6M
EPS (ttm)	-$1.89
Shares out	49.9M
Volume	722,703
Beta	0.69

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -54.6M
EPS (ttm): -$1.89
Market cap: 13.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Metric	Value
Amount currency	USD
CIK code	0001837607
Company name	AEON Biopharma, Inc.
Country	United States
Country code	US
CUSIP number	00791X209
Earnings date	2026-11-13
Earnings time	bmo
Employees	8
Employees change	3
Employees growth	60%
Enterprise value	$12.8M
Exchange	NYSEAMERICAN
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US00791X2099
Last 10-K release date	2026-03-30
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Last stock split date	2025-02-26
Last stock split type	Reverse
Market cap	$13.4M
Market cap category	Nano-Cap
Next earnings date	2026-11-13
Options	No
Price	$0.27
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	AEON
U.S. state	California
Website	https://www.aeonbiopharma.com

Metric

Value

Amount currency

USD

CIK code

0001837607

Company name

AEON Biopharma, Inc.

Country

United States

Country code

CUSIP number

00791X209

Earnings date

2026-11-13

Earnings time

bmo

Employees

Employees change

Employees growth

60%

Enterprise value

$12.8M

Exchange

NYSEAMERICAN

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US00791X2099

Last 10-K release date

2026-03-30

Last earnings date

2026-08-12

Last refreshed

2026-10-28

Last stock split date

2025-02-26

Last stock split type

Reverse

Market cap

$13.4M

Market cap category

Nano-Cap

Next earnings date

2026-11-13

Options

Price

$0.27

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

AEON

U.S. state

California

Website

https://www.aeonbiopharma.com

Metric	Value
Earnings yield	-701.85%
FCF / EV yield	-116.3%
FCF yield	-110.14%
Forward EV/Sales	10.66x
Forward P/S	11.26x
Sector forward P/E	23.53x
Sector P/E	51.01x

Metric

Value

Earnings yield

-701.85%

FCF / EV yield

-116.3%

FCF yield

-110.14%

Forward EV/Sales

10.66x

Forward P/S

11.26x

Sector forward P/E

23.53x

Sector P/E

51.01x

Metric	Value
Profit per employee	$-6.8M
ROA	-141.53%
ROA (5Y)	-295.12%
ROCE	1,389.39%

Metric

Value

Profit per employee

$-6.8M

ROA

-141.53%

ROA (5Y)

-295.12%

ROCE

1,389.39%

Metric	Value
EPS growth quarters	1
EPS growth years	0
Net income growth quarters	1
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$0
Depreciation and amortization	$78,000
EBIT	$-19.9M
EBITDA	$-19.8M
EPS	$-1.89
FCF per share	$-0.27
Financing cash flow	$8.6M
Free cash flow	$-13.6M
Free cash flow minus SBC	$-19.2M
Net cash flow	$-5M
Net income	$-54.6M
Operating cash flow minus SBC	$-19.2M
Operating income	$-19.9M
Stock-based compensation	$5.6M

Metric

Value

Capital expenditures

Depreciation and amortization

$78,000

EBIT

$-19.9M

EBITDA

$-19.8M

EPS

$-1.89

FCF per share

$-0.27

Financing cash flow

$8.6M

Free cash flow

$-13.6M

Free cash flow minus SBC

$-19.2M

Net cash flow

$-5M

Net income

$-54.6M

Operating cash flow minus SBC

$-19.2M

Operating income

$-19.9M

Stock-based compensation

$5.6M

Metric	Value
Book value per share	$-0.58
Long-term assets	$1.9M
Long-term liabilities	$13.9M
Net cash (debt)	$656,000
Net cash / market cap	5.3%
Piotroski F-Score	2
Property, plant and equipment	$1.1M
Shareholders' equity	$-15.4M
Tangible book value	$-15.4M
Tangible book value per share	$-0.58
Total assets	$5.9M
Total cash	$3.4M
Total debt	$2.8M
Total liabilities	$21.3M
WACC	6.56%

Metric

Value

Book value per share

$-0.58

Long-term assets

$1.9M

Long-term liabilities

$13.9M

Net cash (debt)

$656,000

Net cash / market cap

5.3%

Piotroski F-Score

Property, plant and equipment

$1.1M

Shareholders' equity

$-15.4M

Tangible book value

$-15.4M

Tangible book value per share

$-0.58

Total assets

$5.9M

Total cash

$3.4M

Total debt

$2.8M

Total liabilities

$21.3M

WACC

6.56%

Metric	Value
Current assets	$4M
Current liabilities	$7.3M
Current ratio	0.54
Net working capital	$-6.5M
Quick ratio	0.47
Working capital	$-3.3M

Metric

Value

Current assets

$4M

Current liabilities

$7.3M

Current ratio

0.54

Net working capital

$-6.5M

Quick ratio

0.47

Working capital

$-3.3M

Metric	Value
Buyback yield / dilution	-613.82%
Dividend yield	0%
Shareholder yield	-613.82%

Metric

Value

Buyback yield / dilution

-613.82%

Dividend yield

Shareholder yield

-613.82%

Metric	Value
150-day SMA	$0.54
1D price change	8.3%
1M price change	2.01%
1M total return	2.01%
1W price change	16.16%
1W total return	16.16%
1Y price change	-70.45%
1Y return CAGR	-70.48%
1Y total return	-70.45%
20-day SMA	$0.26
200-day SMA	$0.69
3M price change	3.42%
3M total return	3.42%
3Y price change	-99.92%
3Y return CAGR	-90.74%
3Y total return	-99.92%
50-day SMA	$0.26
50-day SMA vs 200-day SMA	50under200
52-week high	$1.45
52-week high date	2026-02-23
52-week low	$0.18
52-week low date	2026-08-20
5Y price change	-99.96%
5Y return CAGR	-79.28%
5Y total return	-99.96%
6M price change	-74.14%
6M total return	-74.14%
All-time high	$1,236.24
All-time high date	2024-03-18
All-time low	$0.18
All-time low date	2026-08-20
Average true range (ATR)	$0.03
Average volume	1.3M
Beta (1Y)	0.58
Beta (2Y)	1.32
Beta (5Y)	0.69
Change from 52-week high	-81.46%
Change from 52-week low	51.75%
Change from all-time high	-99.98%
Change from all-time low	51.75%
Change from open	4.51%
Day's gap	3.62%
Dollar volume	$194,335
High price	$0.27
Low price	$0.26
Monthly RSI	29.86
Open price	$0.26
Position in 52-week range	100%
Premarket change	-1.97%
Premarket close	$0.25
Premarket price	$0.24
Premarket volume	6.8K
Previous close	$0.25
Price vs 150-day SMA	-50.15%
Price vs 20-day SMA	4.67%
Price vs 200-day SMA	-60.76%
Price vs 50-day SMA	4.75%
Relative volume	0.57
RSI	54.55
Sharpe ratio	-0.67
Sharpe ratio (3Y)	-0.78
Sortino ratio	-0.88
Sortino ratio (3Y)	-1.02
Volume	722.7K
Weekly RSI	36.05
YTD price change	-75.55%
YTD total return	-75.55%

Metric

Value

150-day SMA

$0.54

1D price change

8.3%

1M price change

2.01%

1M total return

2.01%

1W price change

16.16%

1W total return

16.16%

1Y price change

-70.45%

1Y return CAGR

-70.48%

1Y total return

-70.45%

20-day SMA

$0.26

200-day SMA

$0.69

3M price change

3.42%

3M total return

3.42%

3Y price change

-99.92%

3Y return CAGR

-90.74%

3Y total return

-99.92%

50-day SMA

$0.26

50-day SMA vs 200-day SMA

50under200

52-week high

$1.45

52-week high date

2026-02-23

52-week low

$0.18

52-week low date

2026-08-20

5Y price change

-99.96%

5Y return CAGR

-79.28%

5Y total return

-99.96%

6M price change

-74.14%

6M total return

-74.14%

All-time high

$1,236.24

All-time high date

2024-03-18

All-time low

$0.18

All-time low date

2026-08-20

Average true range (ATR)

$0.03

Average volume

1.3M

Beta (1Y)

0.58

Beta (2Y)

1.32

Beta (5Y)

0.69

Change from 52-week high

-81.46%

Change from 52-week low

51.75%

Change from all-time high

-99.98%

Change from all-time low

51.75%

Change from open

4.51%

Day's gap

3.62%

Dollar volume

$194,335

High price

$0.27

Low price

$0.26

Monthly RSI

29.86

Open price

$0.26

Position in 52-week range

100%

Premarket change

-1.97%

Premarket close

$0.25

Premarket price

$0.24

Premarket volume

6.8K

Previous close

$0.25

Price vs 150-day SMA

-50.15%

Price vs 20-day SMA

4.67%

Price vs 200-day SMA

-60.76%

Price vs 50-day SMA

4.75%

Relative volume

0.57

RSI

54.55

Sharpe ratio

-0.67

Sharpe ratio (3Y)

-0.78

Sortino ratio

-0.88

Sortino ratio (3Y)

-1.02

Volume

722.7K

Weekly RSI

36.05

YTD price change

-75.55%

YTD total return

-75.55%

Metric	Value
Float	24M
Float percentage	48.13%
Shares change (QoQ)	24.42%
Shares change (YoY)	613.82%
Shares held by insiders	17.68%
Shares held by institutions	26.16%
Shares outstanding	49.9M
Short % of float	9.04%
Short % of shares	4.35%
Short ratio	0.1 days

Metric

Value

Float

24M

Float percentage

48.13%

Shares change (QoQ)

24.42%

Shares change (YoY)

613.82%

Shares held by insiders

17.68%

Shares held by institutions

26.16%

Shares outstanding

49.9M

Short % of float

9.04%

Short % of shares

4.35%

Short ratio

0.1 days

AEON Biopharma, Inc. (AEON)

Price

Financial snapshot

Fair-value bridge

Latest news · AEON

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AEON indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AEON

Frequently asked questions